Harvard Bioscience (HBIO)
(Delayed Data from NSDQ)
$3.62 USD
+0.06 (1.69%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.63 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Industry / Sector Report
Industry : Instruments - Scientific
Zacks Industry Rank
Top 14% (36 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 2.52 | 9.99 |
Current Quarter Estimate | 0.06 | 0.59 | 60.00 |
Year Ago Quarter Estimate | 0.06 | 0.52 | 52.54 |
Next Quarter Estimate | 0.06 | 0.72 | 61.00 |
Next Year Estimate | NA | 2.56 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 64.29 | 5.60 | 17.08 |
Next Year | NA | 18.80 | 8.00 |
Last 5 Years | -10.90 | 5.10 | 8.10 |
Next 5 Years | NA | 11.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 24.13 | 29.86 |
Price/Book (MRQ) | 2.11 | 2.26 |
Price/Cash Flow (MRFY) | 15.84 | 24.22 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -3.04% | 4.34% |
Return on Equity (TTM) | 2.75% | 20.82% |
Debt to Equity (MRQ) | NA | 38.05 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.